Dietary phylloquinone and menaquinones intakes and risk of type 2 diabetes

Diabetes Care. 2010 Aug;33(8):1699-705. doi: 10.2337/dc09-2302. Epub 2010 Apr 27.

Abstract

Objective: To investigate whether dietary phylloquinone and menaquinones intakes are related to risk of type 2 diabetes.

Research design and methods: We used data from a prospective cohort study in 38,094 Dutch men and women, aged 20-70 years. Dietary phylloquinone and menaquinones intakes were assessed using a validated food frequency questionnaire. Diabetes case patients were ascertained mainly via self-report and verified against medical records.

Results: During 10.3 years of follow-up, 918 incident cases of diabetes were documented. In a multivariate model adjusting for diabetes risk factors and dietary factors, phylloquinone intake tended to be associated (P = 0.08) with a reduced risk of type 2 diabetes with a hazard ratio (HR) of 0.81 (95% CI 0.66-0.99) for the highest versus the lowest quartile. For menaquinones intake, a linear, inverse association (P = 0.038) with risk of type 2 diabetes was observed with an HR of 0.93 (0.87-1.00) for each 10-microg increment in the multivariate model.

Conclusions: This study shows that both phylloquinone and menaquinones intakes may be associated with a reduced risk of type 2 diabetes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Diabetes Mellitus, Type 2 / prevention & control*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Prospective Studies
  • Vitamin K 1 / therapeutic use*
  • Vitamin K 2 / therapeutic use*
  • Vitamins / therapeutic use*
  • Young Adult

Substances

  • Vitamins
  • Vitamin K 2
  • Vitamin K 1